Woodford Investment Management Ltd - Q4 2018 holdings

Add to watchlist

$1.16 Billion is the total value of Woodford Investment Management Ltd's 24 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
AUTL BuyAUTOLUS THERAPEUTICS PLCspon ads$391,631,000
+18.0%
11,925,419
+10.2%
33.87%
+28.1%
TBPH BuyTHERAVANCE BIOPHARMA INC$315,180,000
-17.5%
12,316,529
+5.3%
27.26%
-10.4%
PRTA  PROTHENA CORP PLC$122,824,000
-21.3%
11,924,6140.0%10.62%
-14.5%
AGIO BuyAGIOS PHARMACEUTICALS INC$91,181,000
-10.3%
1,977,459
+50.1%
7.89%
-2.5%
ALKS SellALKERMES PLC$77,897,000
-31.0%
2,639,676
-0.8%
6.74%
-25.1%
BIIB SellBIOGEN INC$68,178,000
-34.5%
226,564
-23.1%
5.90%
-28.9%
EVFM  EVOFEM BIOSCIENCES INC$40,196,000
+3.5%
9,593,1970.0%3.48%
+12.3%
NCNA BuyNUCANA PLCspon adr$27,043,000
+89.7%
1,865,000
+226.0%
2.34%
+106.1%
NITE BuyNIGHTSTAR THERAPEUTICS PLCadr$22,134,000
+58.8%
1,921,315
+181.7%
1.91%
+72.4%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2019-08-22
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
PROTHENA CORP PLC19Q2 201937.7%
ALKERMES PLC18Q1 201928.0%
THERAVANCE BIOPHARMA INC17Q3 201971.3%
BIOGEN INC12Q1 20199.8%
ABBVIE INC9Q3 201733.9%
NORTHWEST BIOTHERAPEUTICS INC9Q4 201612.7%
REYNOLDS AMERICAN INC7Q3 201645.9%
EVOFEM BIOSCIENCES INC7Q3 201920.3%
AUTOLUS THERAPEUTICS PLC6Q3 201933.9%
GILEAD SCIENCES INC6Q4 20177.6%

View Woodford Investment Management Ltd's complete holdings history.

Latest significant ownerships (13-D/G)
Woodford Investment Management Ltd Q4 2018 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Evofem Biosciences, Inc.Sold outFebruary 04, 202000.0%
Nightstar Therapeutics plcSold outFebruary 04, 202000.0%
Theravance Biopharma, Inc.November 08, 2019429,7700.8%
Autolus Therapeutics plcOctober 09, 20192,095,1274.7%
NuCana plcSeptember 09, 20191,538,0004.8%
Prothena Corp plcSold outSeptember 09, 201900.0%
NORTHWEST BIOTHERAPEUTICS INCFebruary 14, 201924,815,0284.8%

View Woodford Investment Management Ltd's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G/A2020-02-04
SC 13G/A2020-02-04
13F-HR2020-01-27
13F-HR/A2019-11-12
13F-HR2019-11-08
SC 13G/A2019-11-08
SC 13G/A2019-11-08
SC 13G/A2019-10-09
SC 13G/A2019-09-09
SC 13G/A2019-09-09

View Woodford Investment Management Ltd's complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1156261000.0 != 1156264000.0)
  • The reported has been restated
  • The reported has been amended

Export Woodford Investment Management Ltd's holdings

CSVXLS